Almirall LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$10.3M
Doctors Paid
9,438
Transactions
45,341
2024 Total
$945,338
Payment Breakdown by Category
Research$5.6M (54.3%)
Consulting$1.9M (18.6%)
Food & Beverage$966,932 (9.4%)
Travel$239,983 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.6M | 581 | 54.3% |
| Consulting Fee | $1.9M | 753 | 18.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.4M | 677 | 14.0% |
| Food and Beverage | $966,932 | 42,581 | 9.4% |
| Travel and Lodging | $239,983 | 578 | 2.3% |
| Grant | $108,840 | 1 | 1.1% |
| Honoraria | $24,100 | 10 | 0.2% |
| Education | $1,883 | 160 | 0.0% |
Payments by Type
Research
$5.6M
581 transactions
General
$4.7M
44,760 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| M14867-32 | $1.3M | 2 | 201 |
| Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) | $537,956 | 32 | 147 |
| KLISYRI-IIS US Biomarkers Seykora | $435,617 | 1 | 3 |
| H2200518 - SEYSARA-IIS Dr. Bunick MOA Study | $330,607 | 0 | 2 |
| THE USE OF Sarecycline IN THE TREATMENT OF ROSACEA | $322,373 | 0 | 2 |
| SEYSARA IN THE TREATMENT OF ROSACEA | $322,373 | 0 | 1 |
| Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis (PROAK) | $265,401 | 4 | 58 |
| Elucidating Novel Therapeutic Targets in Hidradenitis Suppurativa | $247,569 | 0 | 4 |
| Mode of action of sarecycline on the bacterial ribosome | $236,984 | 0 | 2 |
| PROAK | $223,535 | 1 | 33 |
| M-27134-01 | $209,035 | 0 | 89 |
| IIS Dr Kircik Patient preference comparing two CAL/BPD fixed dose combinations | $122,000 | 1 | 3 |
| Sarecycline Truncal Acne Safety and Efficacy Response (TASER) Study | $105,000 | 0 | 2 |
| A patient preference study comparing two CAL/BDP fixed dose combinations used for the topical treatment of plaque psoriasis, one formulated as a cream Wynzora and the other as a foam Enstila | $100,000 | 0 | 2 |
| H2200555 KLISYRI-IIS US Tirba SCCIS Lain | $56,058 | 0 | 1 |
| ACZONE GEL IN THE TREATMENT OF ACNE VULGARIS | $52,004 | 0 | 5 |
| PhIV-IIS - RWE Tirbanibulin NMSC | $50,000 | 0 | 2 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Field of Cancerization Size | $50,000 | 0 | 2 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Patient Refusal FU | $41,029 | 0 | 2 |
| ROLE OF ANTIBIOTICS IN THE TREATMENT OF ACNE VULGARIS | $40,000 | 0 | 2 |
| IIS Dr. Lain - Tirbanibulin for sBCC – US | $37,373 | 0 | 1 |
| An open-label study to investigate the efficacy and tolerability of Aczone gel, 7.5% in the treatment of acne vulgaris in men and women with Fitzpatrick skin types IV-VI | $35,478 | 0 | 1 |
| Systematic Review of safety, tolerability and patient-reported outcomes of topical treatments in actinic keratosis | $30,000 | 0 | 2 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Call Backs | $30,000 | 0 | 1 |
| PhIV-IIS - RWE Tirbanibulin for Condyloma Angela Yen Moore | $28,500 | 0 | 2 |
| Research | $20,000 | 0 | 1 |
| A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis | $20,000 | 1 | 1 |
| Perioral Dermatitis IIS | $17,610 | 1 | 2 |
| AD Survey testing | $2,400 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Adelaide Hebert, M.d, M.D | Pediatric Dermatology | Bellaire, TX | $31,091 | $0 |
| Prof. James Krueger, Md, Phd, MD, PHD | Dermatology | New York, NY | $27,592 | $0 |
| Dr. Barbara Gilchrest, Md, MD | Dermatology | Boston, MA | $27,355 | $0 |
| Kara Gooding, Pa C, PA C | Physician Assistant | Scottsdale, AZ | $25,555 | $0 |
| Dr. Joshua Zeichner, Md, MD | Dermatology | New York, NY | $25,111 | $0 |
| Dr. Shani Studnik, Do, DO | Dermatology | Weston, FL | $24,537 | $0 |
| Dr. Christofer Buatti, D.o, D.O | Internal Medicine | Auburn Hills, MI | $24,485 | $0 |
| Dr. Jay Mason, M.d, M.D | Cardiovascular Disease | Reno, NV | $24,429 | $0 |
| Patrick Mcelgunn, M.d, M.D | Dermatology | Charlotte, NC | $23,498 | $0 |
| Dr. Todd Moore, Md, Pa, MD, PA | Clinical & Laboratory Dermatological Immunology | Arlington, TX | $23,047 | $0 |
| Elizabeth Swanson, M.d, M.D | Pediatric Dermatology | Meridian, ID | $22,805 | $0 |
| Dr. Kevin Pinski, M.d, M.D | Procedural Dermatology | Chicago, IL | $22,778 | $0 |
| Tooraj Raoof, Md, MD | Internal Medicine | Encino, CA | $21,722 | $0 |
| Dr. Michael Gold, M.d, M.D | Specialist | Nashville, TN | $21,404 | $0 |
| Dr. Joshua Grosshandler, M.d, M.D | Dermatology | Westerville, OH | $21,308 | $0 |
| Timothy Flynn, M.d, M.D | Dermatology | Cary, NC | $20,651 | $0 |
| Dr. Paul Yamauchi, M.d., Phd, M.D., PHD | Dermatology | Santa Monica, CA | $20,523 | $0 |
| Dr. Harold Farber, M.d,, M.D, | Dermatology | Philadelphia, PA | $20,508 | $0 |
| Dr. Jorge Garcia-Zuazaga, M.d, M.D | Dermatology | Concord Township, OH | $19,712 | $0 |
| Dr. Patrick Brunner, M.d, M.D | Dermatology | New York, NY | $19,239 | $0 |
| Seemal Desai, Md, MD | Dermatology | Plano, TX | $18,917 | $0 |
| Dr. Mark Kory, M.d, M.D | Dermatology | Chesterfield, MO | $18,807 | $0 |
| Dr. Raja Sivamani, M.d., M.s., A.h.e, M.D., M.S., A.H.E | Dermatology | Sacramento, CA | $18,775 | $0 |
| Dr. Lawrence Green, Md, MD | Procedural Dermatology | Rockville, MD | $18,515 | $0 |
| Dr. Judith Andreano, M.d, M.D | Dermatology | Strongsville, OH | $18,176 | $0 |
About Almirall LLC
Almirall LLC has made $10.3M in payments to 9,438 healthcare providers, recorded across 45,341 transactions in the CMS Open Payments database. In 2024, the company paid $945,338. The top product by payment volume is Klisyri ($2.1M).
Payments were distributed across 111 medical specialties. The top specialty by payment amount is Dermatology ($4.1M to 4,066 doctors).
Payment categories include: Food & Beverage ($966,932), Consulting ($1.9M), Research ($5.6M), Travel & Lodging ($239,983).
Almirall LLC is associated with 6 products in the CMS Open Payments database, including Klisyri, Seysara, and SEYSARA.